Elromo 50 mg is a prescription oral medication primarily used to treat low blood platelets count in conditions like chronic immune thrombocytopenia (ITP) and severe aplastic anemia. It stimulates the bone marrow to produce more platelets ,reducing bleeding and bruising. It plays a crucial role in managing low platelet count by reducing bleeding risk and supporting continuous medical treatments like chemotherapy.
WHAT IS ELROMO 50 MG?
Elromo 50 mg is classified as a thrombopoietin (TPO) receptor agonist. It function as a hematopoietic growth factor that stimulate the bone marrow to produce more platelets, reducing risk of bleeding.
Key classification:
• Active ingredient : Eltrombopag 50 mg.
• Role in hematology treatment: used to increase platelets counts and prevent bleeding in patients who have not responded to corticosteroids ,immunoglobins or spleen removal surgery.
WHAT ARE THE MEDICAL USES OF ELROMO 50 MG?
Medical uses of Elromo 50 mg are:
1) TREATMENT OF LOW PLATELET DISORDER
• Chronic immune thrombocytopenia (ITP)
Elromo 50 mg is a standard oral medication used to manage chronic immune thrombocytopenia (ITP) by stimulating the bone marrow to produce platelets. It is typically prescribed for adults and children whose platlets count remain low after prior treatments like corticosteroids ,immunoglobulins or splenectomy.
• Severe Aplastic anemia
In severe Aplastic anemia, it is used to promote multi-lineage blood cell recovery, reduce dependency on transfusions and improve overall response rates.
• Thrombocytopenia associated with chronic liver disease
Elromo 50 mg is an oral thromobopoitein (TPO) receptor agent. Its primary role is to stimulate the bone marrow to produce platelets, thereby safely raising platelet counts in pateints with chronic liver disease (CLD) and severe thrombocytopenia prior to scheduled invasive medical or surgical procedures. It is specifically prescribed to reduced or completely avoid the need for prophylactic platelet transfusions before planned invasive procedures.
2) HEAMATOLOGICAL SUPPORT
- Increasing platelet production
Elromo 50mg is an oral medication designed to increase platelet production in the body. It is commonly prescribed to treat low platelet counts in conditions such as chronic immune thrombocytopenia and severe aplastic anemia. By boosting the number of precursor cells, it rapidly increases the overall production and release of new platelets into the bloodstream.
• Reducing bleeding risks
Elromo 50 mg reduces bleeding risk by stimulating the bone marrow to produce more platelets. It is a thrombopoietin receptor prescribed for adults with chronic immune thrombocytopenia (ITP) , severe aplastic anemia, or low platelets due to hepatitis c. elevating the platelet count helps the blood clot more effectively , minimizing spontaneous bruising and severe bleeding.
• Supporting long-term disease management
Elromo 50mg supports long-term disease management for patients with chronic immune thrombocytopenia (ITP) , severe aplastic anemia, and low platelets associated with hepatitis C. for patients with hepatitis C ,it ensures safe platelet levels so they can start or continue interferon-based antiviral therapies.
HOW ELROMO 50 MG WORKS?
Elromo 50 mg is a targeted medication used to treat low blood platelet counts in conditions like immune thrombocytopenia , severe aplastic anemia, and Hepatitis C
. it works by the following ways:
• Stimulating thrombopoietin receptors
Elromo 50 mg is a targeted thrombopoietin (TPC) receptor against. It stimulates platelets production by binding directly to the transmembrane domain of the TPO receptor promoting cellular signaling cascades that drive cell proliferation ,differentiation and an increase in mature platelets.
• Promoting platelet production in the bone marrow
Elromo 50 mg work as a thrombopoietin (TPO) receptor agonist. This medication is typically prescribed to treat low platelet counts in conditions like chronic immune thrombocytopenia, severe aplastic anemia, and hepatitis c –related thrombocytopenia.
• Helping maintain healthy platelet level
Elromo 50 mg helps maintain healthy platelet levels by acting as a TPO receptor against. This boost the platelet count ,lowering the risk of spontaneous bleeding and bruising. By restoring platelet counts to safer levels, it minimize the risk of hemorrhage ,brushing and severe nosebleeds or gum bleeding.
WHAT ARE THE BENEFITS OF ELROMO 50 MG?
Benefits of Elromo 50 mg are:
1. Reduce risk of bleeding complications
Elromo reduces bleeding risk by stimulating the bone marrow to produce more platelets, which are essential for blood clotting. It is typically prescribed for chronic immune thrombocytes (ITP), severe aplastic anemia, caused by hepatitis C. To effectively reduce the risk of bleeding, ensure the medication works safely, it is critical to manage how it is taken and monitor for side effects.
2. Supports treatment of chronic blood disorders
Elromo 50 mg supports the treatment of chronic blood disorders by stimulating the bone marrow to produce more platelets and blood cells. It act as a thrombopoietin(TPO) receptors to prevent spontaneous bleeding and bruising.
3. Improves patient quality of life
Elromo 50 mg significantly improves patient quality of life by stimulating the bone marrow to increase platelet production, reducing the anxiety , fatigue, and physical limitations associated with spontaneous bruising, bleeding and severe thrombocytopenia
. it improves quality of life by the following ways:
A) Reduces bleeding risk: by elevating platelet counts to safer threshold, the medication prevents life-altering or fatal spontaneous internal and external bleeding episodes.
B) Oral convenience : as a daily tablet, it eliminates the need for frequent , painful injections in clinical settings, granting pateints greater autonomy and mobility.
WHO SHOULD AVOID ELROMO 50 MG?
Elromo 50 mg should be avoided by:
1) Patients allergic to Eltrombopag
2) Individuals with severe liver complications
3) Patient at a high risk of blood clots
4) Cases requiring special dose adjustment
CONCLUSION
Elromo 50 mg is a prescription medication utilized to treat low blood platelets count in individuals with chronic immune thrombocytopenia (ITP) ,severe aplastic anemia, and chronic hepatitis C. it function as a thrombopoietin (TPO) receptor against, which stimulates the bone marrow to produce more platelets and lower the risk of bleeding episodes.
FREQUENTLY ASKED QUESTIONS (FAQs):
QUESTION: WHAT IS ELROMO 50 MG USED FOR?
Eloromo 50 mg is used to treat low blood platelets count in specific conditions where other treatments have been ineffective . it is used to stimulate platelet production in adults and children whose bodies destroy their own platelets ,putting them at high risk of bleeding and brusing.
QUESTION: HOW LONG DOES IT TAKE TO INCREASE PLATELET COUNTS?
For most patients, taking a 50 mg dose of elromo ,platelets counts typically begins to increase within 1 to 2 weeks, with peak responses often observed after 2 to 4 weeks of therapy.
QUESTION: CAN IT BE TAKEN WITH CALCIUM-RICH FOODS?
No one should not take elromo 50 mg with calcium-rich foods. Calcium binds to the medication, preventing the body from absorbing it properly and making it ineffective.
REFRENCES:
1)https://www.apollopharmacy.in/medicine/elromo-50-tablet-7-s?srsltid=AfmBOooS_xLB2j1-8XoiRszJlmAGiHmhVj4ZG2fRb-JUG_7gtPoVo01Q
2)https://oncohealthmart.com/product-details/1591/elromo-50mg-tablet/
